BACKGROUND. Although multifocal neuroblastoma is rare, its incidence has in
creased because of recent improvements in diagnostic tools and the introduc
tion of mass screening. Among the 106 neuroblastoma cases treated at the au
thors' hospital between 1984 and 1998, 8 were multifocal neuroblastoma.
METHODS. The authors examined clinicopathologic findings and biologic featu
res, including MYCN amplification, NTRK1 and Ha-ras p21 expression, cellula
r DNA content, and telomerase activity in these 8 multifocal neuroblastoma
cases. Moreover, clinicopathologic findings were investigated with a review
of 53 published cases of multiple neuroblastoma in the literature publishe
d in English between 1966 and 1999.
RESULTS. Among these eight cases, five were detected by mass screening and
three were incidental neuroblastomas. Histologically, all tumors were class
ified as ganglioneuroma or favorable neuroblastoma except one advanced case
. All tumors lacked the MYCN gene amplification and expressed NTRAK1 mRNA a
nd Ha-ras p21 protein. Cellular DNA content showed that half of these tumor
s were near-triploid, and the proliferative index (%S-phase) of all tumors
was less than 25%. High telomerase activity was detected in none of these c
ases. Four patients underwent multistage operation and five patients with b
ilateral adrenal neuroblastomas underwent tumor enucleation to preserve adr
enal function. Currently, all patients are disease free and none have requi
red corticosteroid replacement therapy. Among the previously reported 53 ca
ses with multifocal neuroblastoma, 25 were incidentally detected, 18 had fa
miliar history, and most patients without other major complications also ha
d extremely good prognoses.
CONCLUSIONS. These findings suggested that most multifocal neuroblastomas h
ave favorable biologic features. Clinically, surgical approaches should be
attempted to preserve organ function, especially adrenal function, and mini
mal invasive surgery should be performed. In cases of thoracoabdominal neur
oblastoma, multistage surgery is effective and safe. Cancer 2000;88:1955-63
. (C) 2000 American Cancer Society.